The M16 mouse: an outbred animal model of early onset polygenic obesity and diabesity
- PMID: 15483204
- DOI: 10.1038/oby.2004.176
The M16 mouse: an outbred animal model of early onset polygenic obesity and diabesity
Abstract
Objective: To characterize the phenotypic consequences of long-term selective breeding for rapid weight gain, with an emphasis on obesity and obesity-induced diabetes (diabesity).
Research methods and procedures: M16 is the result of long-term selection for 3- to 6-week weight gain from an ICR base population. Experiment 1 characterized males from both lines for body weights (3, 6, and 8 weeks), feed (4 to 8 weeks) and H(2)O (6 to 8 weeks) consumption, and heat loss, body composition, and levels of several plasma proteins at 8 weeks of age. Experiment 2 characterized differences between lines for both sexes at three ages (6, 8, and 16 weeks) and fed two diets (high and normal fat). Body weight, composition, blood glucose, and plasma insulin and leptin levels were evaluated after an 8-hour fast.
Results: At all ages measured, M16 mice were heavier, fatter, hyperphagic, hyperinsulinemic, and hyperleptinemic relative to ICR. M16 males and females were hyperglycemic relative to ICR, with 56% and 22% higher fasted blood glucose levels at 8 weeks of age.
Discussion: M16 mice represent an outbred animal model to facilitate gene discovery and pathway regulation controlling early onset polygenic obesity and type 2 diabetic phenotypes. Phenotypes prevalent in the M16 model, with obesity and diabesity exhibited at a young age, closely mirror current trends in human populations.
Similar articles
-
Diabesity: a polygenic model of dietary-induced obesity from ad libitum overfeeding of Sprague-Dawley rats and its modulation by moderate and marked dietary restriction.Toxicol Pathol. 2005;33(6):650-74. doi: 10.1080/01926230500311222. Toxicol Pathol. 2005. PMID: 16207639
-
Adipokine and insulin profiles distinguish diabetogenic and non-diabetogenic obesities in mice.Obesity (Silver Spring). 2007 Aug;15(8):1961-8. doi: 10.1038/oby.2007.234. Obesity (Silver Spring). 2007. PMID: 17712113
-
Adipose cellularity, serum glucose, insulin and cholesterol in polygenic obese mice fed high-fat or high-carbohydrate diets.Growth. 1981 Autumn;45(3):198-215. Growth. 1981. PMID: 7030875
-
Mouse models of obesity.Clin Dermatol. 2004 Jul-Aug;22(4):345-9. doi: 10.1016/j.clindermatol.2004.01.004. Clin Dermatol. 2004. PMID: 15475237 Review.
-
Drosophila: a model for understanding obesity and diabetic complications.Exp Clin Endocrinol Diabetes. 2012 Apr;120(4):184-5. doi: 10.1055/s-0032-1304566. Epub 2012 Mar 8. Exp Clin Endocrinol Diabetes. 2012. PMID: 22402943 Review.
Cited by
-
A Review on In-vivo and In-vitro Models of Obesity and Obesity-Associated Co-Morbidities.Endocr Metab Immune Disord Drug Targets. 2025;25(6):458-478. doi: 10.2174/0118715303312932240801073903. Endocr Metab Immune Disord Drug Targets. 2025. PMID: 39136512 Review.
-
Dopaminergic dysregulation in mice selectively bred for excessive exercise or obesity.Behav Brain Res. 2010 Jul 11;210(2):155-63. doi: 10.1016/j.bbr.2010.02.016. Epub 2010 Feb 13. Behav Brain Res. 2010. PMID: 20156488 Free PMC article.
-
Dietary fat-dependent transcriptional architecture and copy number alterations associated with modifiers of mammary cancer metastasis.Clin Exp Metastasis. 2010 May;27(5):279-93. doi: 10.1007/s10585-010-9326-z. Epub 2010 Mar 31. Clin Exp Metastasis. 2010. PMID: 20354763 Free PMC article.
-
Spontaneous type 2 diabetic rodent models.J Diabetes Res. 2013;2013:401723. doi: 10.1155/2013/401723. Epub 2013 Feb 28. J Diabetes Res. 2013. PMID: 23671868 Free PMC article.
-
Progress in experimental models to investigate the in vivo and in vitro antidiabetic activity of drugs.Animal Model Exp Med. 2024 Jun;7(3):297-309. doi: 10.1002/ame2.12442. Epub 2024 Jun 4. Animal Model Exp Med. 2024. PMID: 38837635 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases